Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Глобальная, региональная и национальная заболеваемость, распространённость и годы жизни с инвалидностью для 310 заболеваний и травм, 1990–2015 гг.: систематический анализ в рамках исследования глобального бремени болезней 2015 года
2016-10-01
SCID: 54.1/t5jrbkwj
Discuss with AI
DisMod-MR 2.1Global Burden of Disease StudySocio-demographic Indexincidence and prevalenceyears lived with disability
Figures from the paper
Abstract (AI)
BACKGROUND: Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015. METHODS: We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures. Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60 900 unique data sources. Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013. For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data. For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores. FINDINGS: We generated 9·3 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year. In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17·2 billion, 95% uncertainty interval [UI] 15·4-19·2 billion) and diarrhoeal diseases (2·39 billion, 2·30-2·50 billion). Eight causes of chronic disease and injury each affected more than 10% of the world's population in 2015: permanent caries, tension-type headache, iron-deficiency anaemia, age-related and other hearing loss, migraine, genital herpes, refraction and accommodation disorders, and ascariasis. The impairment that affected the greatest number of people in 2015 was anaemia, with 2·36 billion (2·35-2·37 billion) individuals affected. The second and third leading impairments by number of individuals affected were hearing loss and vision loss, respectively. Between 2005 and 2015, there was little change in the leading causes of years lived with disability (YLDs) on a global basis. NCDs accounted for 18 of the leading 20 causes of age-standardised YLDs on a global scale. Where rates were decreasing, the rate of decrease for YLDs was slower than that of years of life lost (YLLs) for nearly every cause included in our analysis. For low SDI geographies, Group 1 causes typically accounted for 20-30% of total disability, largely attributable to nutritional deficiencies, malaria, neglected tropical diseases, HIV/AIDS, and tuberculosis. Lower back and neck pain was the leading global cause of disability in 2015 in most countries. The leading cause was sense organ disorders in 22 countries in Asia and Africa and one in central Latin America; diabetes in four countries in Oceania; HIV/AIDS in three southern sub-Saharan African countries; collective violence and legal intervention in two north African and Middle Eastern countries; iron-deficiency anaemia in Somalia and Venezuela; depression in Uganda; onchoceriasis in Liberia; and other neglected tropical diseases in the Democratic Republic of the Congo. INTERPRETATION: Ageing of the world's population is increasing the number of people living with sequelae of diseases and injuries. Shifts in the epidemiological profile driven by socioeconomic change also contribute to the continued increase in years lived with disability (YLDs) as well as the rate of increase in YLDs. Despite limitations imposed by gaps in data availability and the variable quality of the data available, the standardised and comprehensive approach of the GBD study provides opportunities to examine broad trends, compare those trends between countries or subnational geographies, benchmark against locations at similar stages of development, and gauge the strength or weakness of the estimates available. FUNDING: Bill & Melinda Gates Foundation.
Key Findings
1
GBD 2015 estimated incidence, prevalence, and years lived with disability for 310 diseases and injuries across 1990–2015 at global, regional, and national levels.
2
Prevalence and incidence were primarily estimated using the improved Bayesian meta-regression tool DisMod-MR 2.1, supplemented by alternative models for complex conditions.
3
The analysis generated 9.3 billion estimates spanning causes, sequelae, impairments, age groups, sexes, geographies, and years.
4
The estimation database expanded to 60,900 unique data sources through new datasets, updated reviews for 85 causes, and studies published through November 2015.
5
The study introduced the Socio-demographic Index, combining income, education, and fertility, to compare observed health loss with patterns expected for locations at similar development levels.
Research Object
Global, regional, and national burden of 310 diseases and injuries (incidence, prevalence, and years lived with disability) from 1990 to 2015
Research Subject
Incidence, prevalence, and years lived with disability by age, sex, cause, year, and geography
Publication Details
Publication Date
2016-10-01
Journal
Publisher
ISSN
Cited by
7246
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Cited by16
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162017
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 20172018
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 20152016
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162019
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies2018
Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans2017
Measuring biological aging in humans: A quest2019
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 20172020
Evaluation of Galcanezumab for the Prevention of Episodic Migraine2018
Core outcome measurement instruments for clinical trials in nonspecific low back pain2017
Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies2020
Expert consensus on early childhood caries management2022
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis2018
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 20152016